Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Lippman

Showing results (101-110 of 240) with videos related to

Pageof 24
Sort By:
The Western Journal of Medicine|July 1, 1985
Computed tomographic findings in orbital MucorM R Greenberg, S M Lippman, V S Grinnell, et al.
Investigational New Drugs|August 1, 1992
A phase II study of interleukin-2 and interferon-alpha in head and neck cancerS P Schantz, I Dimery, S M Lippman, et al.
Cancer Research|May 27, 1999
Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanismsS Y Sun, W Li, P Yue, et al.
Seminars in Oncology|August 22, 2000
Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directionsF R Khuri, D M Shin, B S Glisson, et al.
Cancer Detection and Prevention|February 18, 1998
The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levelsS M Lippman, S E Benner, H A Fritsche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
The incidence of second primary tumors in long-term survivors of small-cell lung cancerK H Heyne, S M Lippman, J J Lee, et al.
Blood|August 1, 1988
The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotypeS M Lippman, T P Miller, C M Spier, et al.
The Journal of Clinical Investigation|July 1, 1988
HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphomaT P Miller, S M Lippman, C M Spier, et al.
Journal of the National Cancer Institute|April 4, 1990
Biomarkers as intermediate end points in chemoprevention trialsS M Lippman, J S Lee, R Lotan, et al.
Investigational New Drugs|January 1, 1995
Phase II study of cisplatin, 5-fluorouracil and interferon-alpha in recurrent carcinoma of the cervixC Gonzales-de Léon, S M Lippman, A P Kudelka, et al.
Pageof 24

Showing results (101-110 of 240) with videos related to

Sort By:
Pageof 24
The Western Journal of Medicine|July 1, 1985
Computed tomographic findings in orbital MucorM R Greenberg, S M Lippman, V S Grinnell, et al.
Investigational New Drugs|August 1, 1992
A phase II study of interleukin-2 and interferon-alpha in head and neck cancerS P Schantz, I Dimery, S M Lippman, et al.
Cancer Research|May 27, 1999
Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanismsS Y Sun, W Li, P Yue, et al.
Seminars in Oncology|August 22, 2000
Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directionsF R Khuri, D M Shin, B S Glisson, et al.
Cancer Detection and Prevention|February 18, 1998
The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levelsS M Lippman, S E Benner, H A Fritsche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
The incidence of second primary tumors in long-term survivors of small-cell lung cancerK H Heyne, S M Lippman, J J Lee, et al.
Blood|August 1, 1988
The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotypeS M Lippman, T P Miller, C M Spier, et al.
The Journal of Clinical Investigation|July 1, 1988
HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphomaT P Miller, S M Lippman, C M Spier, et al.
Journal of the National Cancer Institute|April 4, 1990
Biomarkers as intermediate end points in chemoprevention trialsS M Lippman, J S Lee, R Lotan, et al.
Investigational New Drugs|January 1, 1995
Phase II study of cisplatin, 5-fluorouracil and interferon-alpha in recurrent carcinoma of the cervixC Gonzales-de Léon, S M Lippman, A P Kudelka, et al.
Pageof 24